ArticleFrontiers in immunology2024

An updated management approach of Pompe disease patients with high-sustained anti-rhGAA IgG antibody titers: experience with bortezomib-based immunomodulation.

Ankit K Desai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.